The effect of RTS,S/AS01E and SMC alone or combined on the acquisition of blood stage antimalarial antibody responses.
2024
(2024).
Does the improved impact of dual active ingredient nets on malaria control last 3 years? Results from randomised controlled trials.
2024
(2024).
School-based malaria chemoprevention as a cost-effective approach to improve cognitive and educational outcomes: a meta-analysis.
2024
(2024).
Identification of the PfK13 mutations R561H and P441L in Democratic Republic of Congo (DRC): and a snapshot of prevalence and diversity at antimalarial drug resistance loci in P. falciparum across the DRC.
2024
(2024).MH4 Category: Drug Resistance 5 Scientific Session N° 56
Concurrent declines in malaria incidence among children under and over five years of age in Koutiala, Mali: time series analysis of seasonal malaria chemoprevention from 2012-2022.
2024
(2024).MH4 Category: Drug Resistance 5 Scientific Session N° 56
A systematic review of non-malarial effects of malaria chemoprevention interventions.
2024
(2024).MH1 Category: Chemoprevention 3 Scientific Session N° 40
Modelling the potential impact of perennial malaria chemoprevention with sulfadoxine pyrimethamine in Cameroon.
2024
(2024).MH4 Category, Chemoprevention 1 Scientific Session N° 6
Characterisation of Plasmodium falciparum antimalarial drug resistance marker profiles in polyclonal/mixed infections by Illumina targeted sequencing.
2024
(2024).MH4 Category: Drug Resistance Scientific Session N° 56
Social determinants of malaria chemoprevention among children in sub-Saharan Africa: a systematic review.
2024
(2024).
